Clinical Trials
Trial: APPRAISE trial (Novartis)
Participating centers: UZ Brussel, CHR (Liège), Virga Jesse (Hasselt), UZ Gent, HH Lier and AZ St Jan (Brugge)
Target population: episodic migraine with previous inadequate response to one or two prior preventive treatments (last treatment in the last 6 months before screening)
Intervention: monoclonal antibody against CGRP injection subcutaneously once per month versus oral prophylactic treatment for twelve months in an open-label fashion
Contact principal investigator: Prof. Dr J Versijpt (02 4763739), Prof. Dr J Schoenen (Liège), Dr A Van Dycke (Brugge), Dr N De Klippel (Hasselt), Prof Dr Koen Paemeleire (Gent) or Dr Peter Dedeken (Lier)
content updated:20190628